This inventor holds 376 USPTO granted patents and 59 published patent applications, plus 11 CIPO patents and 28 EPO patents, primarily in Defibrillation Technology (CPC class A61B5-0006). Top assignees: Bardy Diagnostics, Inc., Cameron Health, Inc., Cardiac Intelligence Corporation. Active years: 1992-2026.
Inventors with similar research interests:
Location History:
- Seatlle, WA (US) (2003 - 2013)
- W. Seattle, WA (US) (2013)
- West Seattle, WA (US) (2006 - 2014)
- Seattle, WA (US) (1992 - 2016)
- Carnation, WA (US) (2008 - 2024)
Company Filing History:
140 out of 144 
97 out of 223 
51 out of 51 
Years Active: 1992-2026
Areas of Expertise:
Title: Gust H Bardy: Advancing Non-Invasive Cardiac Electrophysiology
Introduction:
Gust H Bardy is a renowned inventor and innovator in the field of non-invasive cardiac electrophysiology. With a remarkable track record of 322 patents, Bardy has dedicated his career to developing technologies that enhance cardiac monitoring and diagnosis. This article highlights his latest patents, career highlights, collaborations, and contribution to the field.
Latest Patents:
Bardy's recent patents demonstrate his commitment to advancing non-invasive cardiac monitoring technologies. One notable invention is the "Electrocardiography and Respiratory Monitor." This apparatus employs a strip with adhesive, two electrocardiographic electrodes, a flexible circuit, an accelerometer, a respiratory sensor, and a wireless transceiver. The integration of these components allows for accurate and convenient simultaneous monitoring of ECG and respiratory data.
Another innovative patent from Bardy is the "Electrocardiography Patch." This compact device features a strip with two electrocardiographic electrodes, a flexible circuit with circuit trace connections to the electrodes, a wireless transceiver, a battery, and a separate housing for the processor. The patch offers flexibility, ease of use, and reliable wireless transmission of vital cardiac data.
Career Highlights:
Throughout his career, Bardy has made significant contributions to the field of non-invasive cardiology. He has co-founded reputable companies like Bardy Diagnostics, Inc., and Cameron Health, Inc., where he has played a pivotal role in driving innovation and bringing life-saving technologies to the market.
Collaborations:
Bardy has collaborated with esteemed professionals in the field. Notably, he has worked with Jason Felix, a renowned expert, and Jon Mikalson Bishay, a talented innovator. These collaborations have fostered an environment of knowledge-sharing and teamwork, leading to groundbreaking advancements in non-invasive cardiac electrophysiology.
Conclusion:
Gust H Bardy's relentless pursuit of innovation has revolutionized non-invasive cardiac electrophysiology. His extensive patent portfolio is a testament to his expertise and dedication in developing cutting-edge technologies for cardiac monitoring. Through his contributions, Bardy has enhanced the accuracy, convenience, and effectiveness of non-invasive cardiac monitoring devices, ultimately improving patient outcomes and paving the way for future advancements in this crucial field.
Please note that the company names mentioned in this article have been represented in the most appropriate and commonly recognized format.